Sepsis-Induced Hypotension
Sepsis-Induced Hypotension is a life-threatening condition that occurs when sepsis leads to dangerously low blood pressure, reducing blood flow to vital organs and requiring urgent medical treatment.
Sepsis-Induced Hypotension: REGN7544 Treatment Study
We are studying REGN7544 to see if it can help adults with sepsis-induced hypotension manage their blood pressure and reduce the need for other medications. The trial will also assess the safety and effects of this treatment.
3-6 months6-10 visitsEfficacy phase (II)Cost ReimbursementPartially RemoteInvestigational MedicinesInjectionCardiologyInfectious Diseases
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have a proven or suspected infection that requires treatment with antibiotics?
- Are you currently receiving treatment for low blood pressure that has not improved with fluids?
- Have you had a heart attack, stroke, or serious heart problem in the last 3 months?
- Are you currently taking 3 or more medications to support your blood pressure?
- Have you received chemotherapy or a bone marrow transplant in the last 6 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Regn7544
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire D'Angers
Medical Intensive Care Unit
Angers, France
Centre Hospitalier Universitaire Reims
Medical Intensive Care Unit
Cormontreuil, France
Centre Hospitalier Le Mans
Medical-Surgical Intensive Care Department
Coulaines, France
Sponsor: Regeneron Pharmaceuticals Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.